Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
August 20, 2026
02:30 PM - 03:30 PM ET
1.00 credit
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Susana Campos, MD, MPH; Robert Coleman, MD, FACOG
1.00 credit
- Susana Campos, MD, MPH
- Robert Coleman, MD, FACOG
- Debra Richardson, MD
1.00 credit
Interpreting and Applying cGVHD Clinical Trial Data
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®
Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP; Christopher Graham, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Christopher Graham, MD
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CE
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
MCED Testing for Breast Cancer: Opportunities and Limitations
MCED Testing for Breast Cancer: Opportunities and Limitations
On the Frontlines of Metastatic Breast Cancer
MCED Testing for Breast Cancer: Opportunities and Limitations
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- Jorge Nieva, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
- Urs Weber, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
- Urs Weber, MD

Medical News

Medical News
Urine Tumor DNA Stratifies Recurrence Risk During BCG in High-Risk NMIBC
07/02/2026
Read more
Medical News
Deep Learning Assistance vs Manual Reading in Cervical Cytopathology
07/02/2026
Read more
Medical News
Oncologist Preferences in First-Line Alk-Positive Metastatic NSCLC
06/30/2026
Read more
Medical News
Mediterranean Diet, Fat Intake, and Lung Cancer Outcomes
06/30/2026
Read more

CME/CE

CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas
1.00 credit
ADT Intensification: The Evidence You Can’t Afford to Miss
ADT Intensification: The Evidence You Can’t Afford to Miss
MinuteCE®
ADT Intensification: The Evidence You Can’t Afford to Miss
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
De Novo mHSPC: Recognizing the Patients Who Need More
De Novo mHSPC: Recognizing the Patients Who Need More
MinuteCE®
De Novo mHSPC: Recognizing the Patients Who Need More
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit

Clinical Practice

Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
September 03, 2026
02:00 PM - 03:00 PM ET
1.00 credit
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CE
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
How Genetic Testing Guides Personalized mBC Care
How Genetic Testing Guides Personalized mBC Care
On the Frontlines of Metastatic Breast Cancer
How Genetic Testing Guides Personalized mBC Care
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
- Urs Weber, MD

Programs

Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Project Oncology®
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS; Neil M. Iyengar, MD
- Alexandria May, PharmD, BCPS
- Neil M. Iyengar, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
- Urs Weber, MD
Rising Colorectal Cancer in Young Adults: Implications for Screening
Rising Colorectal Cancer in Young Adults: Implications for Screening
Clinician's Roundtable
Rising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
- Christopher Cann, MD
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Project Oncology®
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Steve Jackson, PharmD; Nisha Joseph, MD
- Steve Jackson, PharmD
- Nisha Joseph, MD